Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Argentia Gold is a Canadian licensed cannabis producer based in Newfoundland and Labrador, focused on supplying fresh dried flower, pre-rolls, and infused cannabis products to the local and broader Canadian market. The company operates an approximately 80,000-square-foot facility at the Port of Argentia and holds Health Canada licenses for cultivation, processing, and sales. Argentia Gold has positioned itself as a regional cannabis brand with plans spanning edibles, beverages, topicals, cosmetics, and other cannabinoid-infused consumer products. Its business appears centered on commercial cannabis production and provincial distribution rather than traditional drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Argentia Gold.